Option Care Health Inc(OPCH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 17.88 | EPS (ttm) | 1.32 | Insider Own | 1.76% | Shs Outstand | 149.8M | Perf Week | -0.92% |
| Market Cap | 3.54B | Forward P/E | 11.34 | EPS next Y | 10.83% | Insider Trans | 3.51% | Shs Float | 147.2M | Perf Month | -1.87% |
| Enterprise Value | 4.61B | PEG | 1.08 | EPS next Q | 0.49 | Inst Own | 106.88% | Short Float | 8.18% | Perf Quarter | 10.52% |
| Income | 0.21B | P/S | 0.62 | EPS this Y | 9.29% | Inst Trans | -40.41% | Short Ratio | 5.08 | Perf Half Y | -20.65% |
| Sales | 5.69B | P/B | 2.81 | EPS next 5Y | 10.51% | ROA | 6.2% | Short Interest | 12.04M | Perf YTD | -25.83% |
| Book/sh | 8.41 | P/C | 18.27 | EPS past 3/5Y | 15.4% - | ROE | 16% | 52W High | -35.79% ($36.80) | Perf Year | -17.67% |
| Cash/sh | 1.29 | P/FCF | 11.65 | Sales past 3/5Y | 12.72% 13.25% | ROIC | 8.39% | 52W Low | 31.2% ($18.01) | Perf 3Y | -31.17% |
| Dividend Est. | - | EV/EBITDA | 11.39 | EPS Y/Y TTM | 5.33% | Gross Margin | 17.87% | Volatility(W/M) | 1.97% 2.15% | Perf 5Y | -9.08% |
| Dividend TTM | - | EV/Sales | 0.81 | Sales Y/Y TTM | 5.95% | Oper. Margin | 5.86% | ATR (14) | 0.58 | Perf 10Y | 122.92% |
| Dividend Ex-Date | - | Quick Ratio | 0.98 | EPS Q/Q | 14.13% | Profit Margin | 3.68% | RSI (14) | 50.91 | Recom | 1.79 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.47 | Sales Q/Q | 1.86% | SMA20 | -0.54% ($23.76) | Beta | 0.58 | Target Price | $28.58 |
| Payout | - | Debt/Eq | 1.01 | Earnings | 2026/7/29 | SMA50 | 3.04% ($22.93) | Rel Volume | 0.66 | Prev Close | $23.64 |
| Employees | 6528 | LT Debt/Eq | 0.98 | EPS/Sales Surpr. | 5.56% 1.6% | SMA200 | -12.88% ($27.12) | Avg Volume(3M) | 2.37M | Price | $23.63 |
| IPO | 1996/8/15 | Option/Short | Yes/Yes | Trades | 18828 | Volume | 1,568,105 | Change | -0.04% |
Company
OPCH is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💉 This is a U.S. healthcare services company that provides home infusion therapy services. It delivers drug compounding and nursing services that allow patients to receive intravenous treatments at home or in non-hospital settings, giving it exposure to demand for the treatment of both chronic and acute conditions. It is a company in the home infusion therapy sector.
Over the past 1 year, roughly in the middle
36% below its 1-year high.
OPCH earns at a steady pace
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +9.3% this year.
Tap to view numbers
The price looks about right
Trading at 17.9 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -31.2% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 106.9%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
DOCK 0.02%
XHS 0.02%
TSME 0.01%
SOVF 0.01%
SRHQ 0.01%It ranks #4 in the industry
Based on market cap of $4B.
OPCH $4B PER 17.9
HCA $91B PER 14.1
THC $21B PER 10.2
EHC $12B PER 19.7
FAQ
What kind of company is OPCH?
OPCH belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of OPCH?
The market cap of OPCH is approximately $3.5B, ranking 1,640 within its sector.
What is the P/E ratio of OPCH?
OPCH has a P/E ratio of approximately 17.9x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for OPCH?
OPCH has recorded a 52-week high of $36.80 and a low of $18.01.
